Treatment of nonalcoholic steatohepatitis: antioxidants or insulin sensitizers?
Adams
Leon A
LA
Angulo
Paul
P
D020155:3-Hydroxybutyric Acid / Q000032:analysis; D000410:Alanine Transaminase / Q000032:analysis; D000975:Antioxidants / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005234:Fatty Liver / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance / Q000502:physiology; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*; D014810:Vitamin E / Q000627:therapeutic use*
D000975:Antioxidants; D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D007328:Insulin; D045162:Thiazolidinediones; D014810:Vitamin E; D000410:Alanine Transaminase; D005947:Glucose; D020155:3-Hydroxybutyric Acid; D000077205:Pioglitazone